ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$26.54
+0.10 (+0.36%)
Open$26.32
Previous Close$26.44
Day High$26.92
Day Low$26.18
52W High$39.71
52W Low$18.50
Volume—
Avg Volume111.6K
Market Cap530.31M
P/E Ratio—
EPS$-1.29
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
-58.8% upside
Current
$26.54
$26.54
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 128.89M | 44.93M | 300.07M |
| Net Income | -10,913,966 | -56,963,075 | 8.49M |
| Profit Margin | -8.5% | -133.8% | 2.8% |
| EBITDA | -21,372,267 | -67,781,254 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | — | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |